tiprankstipranks
L&K BIOMED Co., Ltd. (KR:156100)
:156100
South Korea Market

L&K BIOMED Co., Ltd. (156100) Price & Analysis

Followers

156100 Stock Chart & Stats

₩4365.00
₩365.00(9.13%)
--

156100 FAQ

What was L&K BIOMED Co., Ltd.’s price range in the past 12 months?
L&K BIOMED Co., Ltd. lowest stock price was ₩2730.00 and its highest was ₩16400.00 in the past 12 months.
    What is L&K BIOMED Co., Ltd.’s market cap?
    L&K BIOMED Co., Ltd.’s market cap is ₩89.40B.
      When is L&K BIOMED Co., Ltd.’s upcoming earnings report date?
      L&K BIOMED Co., Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 88 days.
        How were L&K BIOMED Co., Ltd.’s earnings last quarter?
        L&K BIOMED Co., Ltd. released its earnings results on Aug 14, 2026. The company reported ₩338.784 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
          Is L&K BIOMED Co., Ltd. overvalued?
          According to Wall Street analysts L&K BIOMED Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does L&K BIOMED Co., Ltd. pay dividends?
            L&K BIOMED Co., Ltd. does not currently pay dividends.
            What is L&K BIOMED Co., Ltd.’s EPS estimate?
            L&K BIOMED Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does L&K BIOMED Co., Ltd. have?
            L&K BIOMED Co., Ltd. has 22,351,152 shares outstanding.
              What happened to L&K BIOMED Co., Ltd.’s price movement after its last earnings report?
              L&K BIOMED Co., Ltd. reported an EPS of ₩338.784 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.242%.
                Which hedge fund is a major shareholder of L&K BIOMED Co., Ltd.?
                Currently, no hedge funds are holding shares in KR:156100
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  L&K BIOMED Co., Ltd. (156100) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  DongKoo Bio & Pharm Co. Ltd.
                  Cellumed Co., Ltd.
                  CORESTEMCHEMON Inc.
                  OSTEONIC Co., Ltd.
                  T&R Biofab Co., Ltd
                  Popular Stocks